SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-24-000721
Filing Date
2024-09-23
Accepted
2024-09-23 18:05:24
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGEDWARD T. MATHERSFOREST BASKETTMOHAMAD H. MAKHZOUMINEA 17 GP, LLCNEA PARTNERS 17, L.P.PAUL WALKERRICK YANGSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D nea17-mbx_18882.htm SC 13D 467104
  Complete submission text file 0001072613-24-000721.txt   469024
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 17, L.P. (Filed by) CIK: 0001768564 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Subject) CIK: 0001776111 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94623 | Film No.: 241317226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)